4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Intermediate High Purity

Inkcazelo emfutshane:

4-[(4-Methylpiperazin-1-yl)methyl]benzoic Acid Dihydrochloride

CAS: 106261-49-8

Imbonakalo: Mhlophe ukuya Phantse kuMhlophe uPowder ukuya kwiCrystal

Ubunyulu: ≥98.0% (HPLC)

Phakathi kwe-Imatinib Mesylate (CAS: 220127-57-1) kunyango lwe-Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph + CML)

Umgangatho ophezulu, iMveliso yoRhwebo

Inquiry: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Iipropati zeMichiza:

Igama leMchiza 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride
Izithethantonye I-Imatinib Mesylate ePhakathi
Inombolo yeCAS 106261-49-8
Inombolo yeCAT RF-PI229
Ubume beStokhwe Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli I-C13H20Cl2N2O2
Ubunzima beMolekyuli 307.22
Indawo yokunyibilika 305.0~307.0℃
Ukunyibilika Inyibilika emanzini
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo Mhlophe ukuya Phantse uMhlophe uPowder ukuya kwiCrystal
Ubunyulu / Indlela yokuHlalutya ≥98.0% (HPLC)
Ilahleko ekomisweni ≤0.50%
Intsalela ekutshisweni ≤0.50%
Ukungcola ngokupheleleyo ≤2.0%
Ukungacoceki okuphezulu okukodwa ≤1.0%
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa I-Pharmaceutical Intermediate ye-Imatinib Mesylate (CAS: 220127-57-1)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.

Izinto eziluncedo:

1

FAQ:

Isicelo:

I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-4-[(4-Methylpiperazin-1-yl) methyl]benzoic acid dihydrochloride (CAS: 106261-49-8) enomgangatho ophezulu.Yonayindawo ephakathi ngokuqhelekileyo kwi-synthesis ye-Imatinib Mesylate (CAS: 220127-57-1).I-Imatinib Mesylate yi-tyrosine kinase inhibitor, ecacileyo kakhulu kwi-BCR-ABL, iyeza lomlomo lonyango lwezigulane zabantu abadala abane-Philadelphia chromosome positive chronic myeloid leukemia (CML) kwisigaba esinzima kunye neendlela ezithile ze-acute lymphoblastic leukemia (ALL), ikhawuleza. isigaba kunye nesigaba esingapheliyo emva kokungaphumeleli kwonyango lwe-interferon.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi